By

Luke Timmerman

25
Mar
2021

A Glimpse Into a Price-Controlled Future

Imagine if H.R. 3 — the drug price-control bill that has significant support in the House of Representatives — were to become law. What would it look like if some of the bill’s provisions, like indexing US prices to 120 percent of prices in Europe, were enacted? How would entrepreneurs adapt? What types of drug discovery programs might be prioritized,...
Read More